{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:30:26Z","timestamp":1790721026982,"version":"4.1.0"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The objective of the review was to synthesize the evidence of the effectiveness of lifestyle-based interventions for mitigating absolute cardiovascular disease (CVD) risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Evidence-based guidelines recommend employing an absolute CVD risk score to inform the selection and intensity of preventive interventions. However, studies employing this strategy have reported mixed results, hence the need for a systematic review of the current evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Inclusion criteria:<\/jats:title>\n                    <jats:p>Studies published in English that included a lifestyle-based intervention to mitigate CVD risk were considered. Studies were eligible if they enrolled individuals aged \u226518 years, with no history of CVD at baseline. The primary outcome was change in absolute CVD risk score post-intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      PubMed, Embase, and CINAHL searches were conducted from database inception to February 2022. The trial registers searched included Cochrane Central Register of Controlled Trials (CENTRAL) and ClinicalTrials.gov. Searches for unpublished studies\/gray literature were conducted in ProQuest Dissertations and Theses Global, GreyLit Report, and OCLC First Search Proceedings. Two independent reviewers selected the studies and critically appraised them for methodological quality using JBI tools. Data extraction was performed for main outcome variables. Data were presented using separate pooled statistical meta-analysis for quasi-experimental and randomized clinical trials. Random effects models were employed in the analyses. Effect sizes (Cohen\u2019s d) were expressed as standardized mean difference at 95% CI. Heterogeneity was assessed via Cochran\u2019s Q statistic, and the inconsistency index (\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      ) was used to describe variability in effect estimates due to heterogeneity rather than sampling error.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Twenty-nine studies with a total sample of 5490 adults with no CVD at baseline were included. Fifteen were randomized controlled trials (RCTs; n=3605) and 14 were quasi-experimental studies (n=1885). The studies were conducted in Europe (n=18), the United States (n = 5), Asia (n=3), Mexico (n=1), Canada (n = 1), and Australia (n=1) and included the following lifestyle interventions: diet, physical activity, motivational interviewing, problem-solving, psychological counseling, cardiovascular risk assessment and feedback, health self-management education, and peer support. Six validated absolute CVD risk assessment tools were used to measure the study outcomes, including Framingham, SCORE, Heart Health Risk Assessment Score, Dundee, ASSIGN, and The UK Prospective Diabetes Study risk score. Overall, the methodological rigor of the RCTs and quasi-experimental studies was high. Of the 15 RCTs included in the meta-analysis, lifestyle intervention was favored over control in reducing absolute CVD risk score (Cohen\u2019s d = \u20130.39;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.032; Z= \u20132.14;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 96). Similarly, in the 14 quasi-experimental studies, the absolute CVD risk score after lifestyle intervention was significantly lower compared to baseline (Cohen\u2019s d = \u20130.39;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001; Z= \u20133.54;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      <jats:italic toggle=\"yes\">=<\/jats:italic>\n                      88). RCTs that combined diet and physical activity reported no significant impact on absolute CVD risk score, but those that used either intervention independently reported significant improvement in the absolute CVD risk score.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>There is evidence supporting the positive impact of lifestyle modification on absolute CVD risk score in adult populations without CVD. Our analysis further suggests that diet and physical activity had significant impact on absolute CVD risk, and a variety of validated screening tools can be used to monitor, evaluate, and communicate changes in absolute risk score after lifestyle modification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Supplemental digital content:<\/jats:title>\n                    <jats:p>A Spanish-language version of the abstract of this review is available [http:\/\/links.lww.com\/SRX\/A29].<\/jats:p>\n                  <\/jats:sec>","DOI":"10.11124\/jbies-22-00356","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T04:00:09Z","timestamp":1691467209000},"page":"4-65","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":29,"title":["Impact of lifestyle-based interventions on absolute cardiovascular disease risk: a systematic review and meta-analysis"],"prefix":"10.11124","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2423-6029","authenticated-orcid":false,"given":"Jacob K.","family":"Kariuki","sequence":"first","affiliation":[{"name":"Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0666-3142","authenticated-orcid":false,"given":"Christopher C.","family":"Imes","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8487-0921","authenticated-orcid":false,"given":"Sandra J.","family":"Engberg","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Scott","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3481-5737","authenticated-orcid":false,"given":"Mary L.","family":"Klem","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1520-2775","authenticated-orcid":false,"given":"Yamnia I.","family":"Cortes","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1]]},"reference":[{"key":"R1-20250613","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics\u20142017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"issue":"25","key":"R3-20250613","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R4-20250613","doi-asserted-by":"crossref","first-page":"E254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"issue":"10","key":"R5-20250613","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIRCULATIONAHA.115.019904","article-title":"Modelling future cardiovascular disease mortality in the united states: national trends and racial and ethnic disparities","volume":"133","author":"Pearson-Stuttard","year":"2016","journal-title":"Circulation"},{"issue":"8","key":"R7-20250613","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIR.0b013e3182285a81","article-title":"Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association","volume":"124","author":"Weintraub","year":"2011","journal-title":"Circulation"},{"issue":"25 Suppl 2","key":"R9-20250613","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"R11-20250613","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2016.05.037","article-title":"2016 European guidelines on cardiovascular disease prevention in clinical practice","volume":"252","author":"Piepoli","year":"2016","journal-title":"Atherosclerosis"},{"issue":"14","key":"R12-20250613","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2009.07.020","article-title":"Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians","volume":"54","author":"Cooney","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"R14-20250613","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"R15-20250613","first-page":"374","article-title":"Alimentary habits, physical activity, and Framingham global risk score in metabolic syndrome","volume":"102","author":"Soares","year":"2014","journal-title":"Arq Bras Cardiol"},{"issue":"7","key":"R16-20250613","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1525-1497.2006.00495.x","article-title":"A multidimensional integrative medicine intervention to improve cardiovascular risk","volume":"21","author":"Edelman","year":"2006","journal-title":"J Gen Intern Med"},{"issue":"8","key":"R17-20250613","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1503\/cmaj.061059","article-title":"One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk","volume":"177","author":"Wister","year":"2007","journal-title":"Can Med Assoc J"},{"issue":"465","key":"R18-20250613","first-page":"291","article-title":"Individualised multifactorial lifestyle intervention trial for high-risk cardiovascular patients in primary care","volume":"51","author":"Ketola","year":"2001","journal-title":"Br J Gen Pract"},{"key":"R19-20250613","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ypmed.2016.02.033","article-title":"Six-month changes in ideal cardiovascular health vs. Framingham 10-year coronary heart disease risk among young adults enrolled in a weight loss intervention","volume":"86","author":"Barone","year":"2016","journal-title":"Prev Med (Baltim)"},{"key":"R20-20250613","doi-asserted-by":"crossref","first-page":"i2416","DOI":"10.1136\/bmj.i2416","article-title":"Prediction models for cardiovascular disease risk in the general population: systematic review","volume":"353","author":"Damen","year":"2016","journal-title":"BMJ"},{"issue":"18","key":"R21-20250613","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"issue":"11","key":"R22-20250613","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"issue":"6805","key":"R24-20250613","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/bmj.303.6805.744","article-title":"The Dundee coronary risk-disk for management of change in risk factors","volume":"303","author":"Tunstall-Pedoe","year":"1991","journal-title":"BMJ"},{"issue":"7110","key":"R25-20250613","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/bmj.315.7110.722","article-title":"Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study","volume":"315","author":"Tunstall-Pedoe","year":"1997","journal-title":"BMJ"},{"issue":"6","key":"R26-20250613","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/cs1010671","article-title":"The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56)","volume":"101","author":"Stevens","year":"2001","journal-title":"Clin Sci"},{"issue":"9921","key":"R29-20250613","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","article-title":"The Framingham Heart Study and the epidemiology of cardiovascular diseases: a historical perspective","volume":"383","author":"Mahmood","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"R30-20250613","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"3","author":"Moher","year":"2009","journal-title":"Open Med"},{"issue":"Suppl 1","key":"R32-20250613","first-page":"29","article-title":"Meta-analysis in medical research","volume":"14","author":"Haidich","year":"2010","journal-title":"Hippokratia"},{"issue":"7414","key":"R33-20250613","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"7652","key":"R35-20250613","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"R36-20250613","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2013GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R37-20250613","doi-asserted-by":"crossref","first-page":"a744","DOI":"10.1136\/bmj.a744","article-title":"Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive","volume":"337","author":"Jaeschke","year":"2008","journal-title":"BMJ"},{"key":"R38-20250613","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"10","key":"R39-20250613","doi-asserted-by":"crossref","first-page":"e004217","DOI":"10.1161\/JAHA.116.004217","article-title":"Effects of a health-partner intervention on cardiovascular risk","volume":"5","author":"Al Mheid","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"458","key":"R40-20250613","first-page":"712","article-title":"Observed changes in the lipid profile and calculated coronary risk in patients given dietary advice in primary care","volume":"50","author":"Price","year":"2000","journal-title":"Br J Gen Pract"},{"issue":"1","key":"R41-20250613","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ahj.2013.09.019","article-title":"Using an online, personalized program reduces cardiovascular risk factor profiles in a motivated, adherent population of participants","volume":"167","author":"Widmer","year":"2014","journal-title":"Am Heart J"},{"issue":"2","key":"R42-20250613","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/JCN.0b013e3181ec02ae","article-title":"Effects of a cardiovascular risk reduction intervention with psychobehavioral strategies for Korean adults with type 2 diabetes and metabolic syndrome","volume":"26","author":"Kim","year":"2011","journal-title":"J Cardiovasc Nurs"},{"issue":"4","key":"R43-20250613","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2143\/AC.63.4.2033048","article-title":"Effects of regular exercise on cardiovascular risk factors profile and oxidative stress in obese type 2 diabetic patients in regard to SCORE risk","volume":"63","author":"Lazarevic","year":"2008","journal-title":"Acta Cardiol"},{"issue":"1","key":"R44-20250613","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jbmr.2608","article-title":"Long-term exercise and bone mineral density changes in postmenopausal women\u2014are there periods of reduced effectiveness?","volume":"31","author":"Kemmler","year":"2016","journal-title":"J Bone Mineral Res"},{"issue":"5","key":"R45-20250613","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/07315724.2005.10719486","article-title":"Dietary exchange of an olive oil and sunflower oil blend for extra virgin olive oil decreases the estimate cardiovascular risk and LDL and apolipoprotein aii concentrations in postmenopausal women","volume":"24","author":"R\u00f3denas","year":"2005","journal-title":"J Am Coll Nutr"},{"issue":"10","key":"R46-20250613","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.ejcn.1601235","article-title":"Short-term changes of cardiovascular risk factors after a non-pharmacological body weight reduction program","volume":"55","author":"Sartorio","year":"2001","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"R47-20250613","doi-asserted-by":"crossref","first-page":"21","DOI":"10.55503\/2790-6744.1050","article-title":"The effect of cardiac health promotion program among the general public in Hong Kong","volume":"20","author":"Chan","year":"2012","journal-title":"J Hong Kong College Cardiol"},{"issue":"16","key":"R48-20250613","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijerph17165910","article-title":"Can active aerobic exercise reduce the risk of cardiovascular disease in prehypertensive elderly women by improving HDL cholesterol and inflammatory markers?","volume":"17","author":"Ahn","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"R49-20250613","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/1741826710389364","article-title":"Six-month programme on lifestyle changes in primary cardiovascular prevention: a telemedicine pilot study","volume":"18","author":"Bernocchi","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"R50-20250613","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2261-8-18","article-title":"Healthy hearts - a community-based primary prevention programme to reduce coronary heart disease","volume":"8","author":"Richardson","year":"2008","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"R51-20250613","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/02813432.2016.1248649","article-title":"Observed changes in cardiovascular risk factors among high-risk middle-aged men who received lifestyle counselling: a 5-year follow-up","volume":"34","author":"Siren","year":"2016","journal-title":"Scand J Prim Health Care"},{"issue":"3","key":"R52-20250613","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3928\/01484834-20150218-16","article-title":"A neighborhood-centered clinical project: improving diabetes and cardiovascular outcomes in Hispanic women","volume":"54","author":"Baldwin","year":"2015","journal-title":"J Nurs Educ"},{"issue":"5","key":"R53-20250613","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jamacardio.2016.1035","article-title":"A digital health intervention to lower cardiovascular risk: a randomized clinical trial","volume":"1","author":"Anand","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"7020","key":"R54-20250613","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1136\/bmj.311.7020.1609","article-title":"Health checks and coronary risk: further evidence from a randomised controlled trial","volume":"311","author":"Hanlon","year":"1995","journal-title":"BMJ"},{"issue":"2","key":"R56-20250613","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archinternmed.2009.499","article-title":"Exercise effects on bone mineral density, falls, coronary risk factors, and health care costs in older women: the randomized controlled senior fitness and prevention (SEFIP) study","volume":"170","author":"Kemmler","year":"2010","journal-title":"Arch Intern Med"},{"issue":"4","key":"R57-20250613","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/gme.0b013e3181cc4a00","article-title":"Effect of exercise and Cimicifuga racemosa (CR BNO 1055) on bone mineral density, 10-year coronary heart disease risk, and menopausal complaints: the randomized controlled Training and Cimicifuga racemosa Erlangen (TRACE) study","volume":"17","author":"Bebenek","year":"2010","journal-title":"Menopause"},{"issue":"2","key":"R58-20250613","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.nut.2005.05.007","article-title":"Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women","volume":"22","author":"Lukaczer","year":"2006","journal-title":"Nutrition"},{"issue":"2","key":"R59-20250613","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2337\/dc11-1443","article-title":"Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized,controlled trial","volume":"35","author":"Curtis","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"R60-20250613","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.1152\/ajpendo.00102.2007","article-title":"Calorie restriction or exercise: effects on coronary heart disease risk factors. A randomized, controlled trial","volume":"293","author":"Fontana","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"R61-20250613","doi-asserted-by":"crossref","first-page":"e49297","DOI":"10.1371\/journal.pone.0049297","article-title":"Effect of high- versus low-intensity supervised aerobic and resistance training on modifiable cardiovascular risk factors in type 2 diabetes; the Italian Diabetes and Exercise Study (IDES)","volume":"7","author":"Balducci","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"R62-20250613","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1463-1326.2007.00731.x","article-title":"A prospective randomized controlled trial of lifestyle intervention on quality of life and cardiovascular risk score in patients with obesity and type 2 diabetes","volume":"9","author":"Tuthill","year":"2007","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"R63-20250613","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1186\/s12889-016-3538-3","article-title":"Cardiovascular risk outcome and program evaluation of a cluster randomised controlled trial of a community-based, lay peer led program for people with diabetes","volume":"16","author":"Riddell","year":"2016","journal-title":"BMC Public Health"},{"key":"R64-20250613","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1479-5868-10-47","article-title":"Motivational interviewing and problem solving treatment to reduce type 2 diabetes and cardiovascular disease risk in real life: a randomized controlled trial","volume":"10","author":"Lakerveld","year":"2013","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"1","key":"R65-20250613","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0300-8932(09)70025-9","article-title":"[Clinical effect of lifestyle modification on cardiovascular risk in prehypertensives: PREHIPER I study]","volume":"62","author":"M\u00e1rquez-Celedonio","year":"2009","journal-title":"Rev Esp Cardiol"},{"issue":"1","key":"R66-20250613","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5334\/aogh.2496","article-title":"Personalized e-coaching in cardiovascular risk reduction: a randomized controlled trial","volume":"85","author":"Khanji","year":"2019","journal-title":"Ann Glob Health"},{"issue":"7","key":"R67-20250613","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.3390\/ijerph18073621","article-title":"Effectiveness of an intervention aimed at improving information for patients with high cardiovascular risk: INFORISK clinical trial","volume":"18","author":"Brotons","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"2037","key":"R68-20250613","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1126\/science.79.2037.38","article-title":"The method of probits","volume":"79","author":"Bliss","year":"1934","journal-title":"Science"},{"key":"R69-20250613","doi-asserted-by":"crossref","first-page":"42103","DOI":"10.1136\/bmjopen-2020-042103","article-title":"Are interventions to improve cardiovascular disease risk factors in premenopausal women effective? A systematic review and meta-analysis","volume":"11","author":"Gao","year":"2021","journal-title":"BMJ Open"},{"issue":"25","key":"R70-20250613","doi-asserted-by":"crossref","first-page":"E1162","DOI":"10.1161\/CIR.0000000000000638","article-title":"Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the American Heart Association and American College of Cardiology","volume":"139","author":"Lloyd-Jones","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"R71-20250613","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/1559827618812395","article-title":"lifestyle strategies for risk factor reduction, prevention, and treatment of cardiovascular disease","volume":"13","author":"Rippe","year":"2019","journal-title":"Am J Lifestyle Med"},{"issue":"4","key":"R72-20250613","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/nu12041088","article-title":"Dietary factors and risks of cardiovascular diseases: an umbrella review","volume":"12","author":"Chareonrungrueangchai","year":"2020","journal-title":"Nutrients"},{"issue":"18","key":"R73-20250613","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.3390\/molecules25184320","article-title":"The effects of flavonoids in cardiovascular diseases","volume":"25","author":"Cium\u0103rnean","year":"2020","journal-title":"Molecules"},{"issue":"4","key":"R74-20250613","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/eurheartj\/ehr441","article-title":"Plant sterols and cardiovascular disease: a systematic review and meta-analysis","volume":"33","author":"Genser","year":"2012","journal-title":"Eur Heart J"},{"issue":"4","key":"R75-20250613","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ije\/31.4.817","article-title":"A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study","volume":"31","author":"Thomsen","year":"2002","journal-title":"Int J Epidemiol"}],"container-title":["JBI Evidence Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-22-00356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:33:44Z","timestamp":1786451624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-22-00356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.11124\/jbies-22-00356","relation":{},"ISSN":["2689-8381"],"issn-type":[{"value":"2689-8381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,7]]}}}